Evidence map›Paper›PMID 27852793›Full record

ArticleThe Journal of experimental medicine2016

Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication.

Shahzada Khan, Erik M Woodruff, Martin Trapecar, Krystal A Fontaine, Ashley Ezaki, Timothy C Borbet, Melanie Ott, Shomyseh Sanjabi

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Zika virus infection in the genital tract of non-pregnant females: a systematic review.Revista do Instituto de Medicina Tropical de Sao Paulo · 2020
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Pathogenesis of Zika Virus Infection.Annual review of pathology · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shahzada KhanVirology and Immunology, Gladstone Institutes, San Francisco, CA 94158.ORCID 0000-0003-2975-6621
Erik M WoodruffVirology and Immunology, Gladstone Institutes, San Francisco, CA 94158.
Martin TrapecarVirology and Immunology, Gladstone Institutes, San Francisco, CA 94158.
Krystal A FontaineVirology and Immunology, Gladstone Institutes, San Francisco, CA 94158.
Ashley EzakiVirology and Immunology, Gladstone Institutes, San Francisco, CA 94158.
Timothy C BorbetVirology and Immunology, Gladstone Institutes, San Francisco, CA 94158.ORCID 0000-0001-7638-6382
Melanie OttVirology and Immunology, Gladstone Institutes, San Francisco, CA 94158.
Shomyseh SanjabiVirology and Immunology, Gladstone Institutes, San Francisco, CA 94158 shomyseh.sanjabi@gladstone.ucsf.edu.ORCID 0000-0002-3097-9665
Gladstone Institutes · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
Characterizing HIV latent reservoir in vivoDP2AI112244 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI SANJABI, SHOMYSEH · 2013 to 2013
$2.8M
Role of Lipid Droplets in Hepatitis C Virus InfectionR01AI097552 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI OTT, MELANIE MARIA · 2014 to 2018
$2.4M
EXTRAMULAR RESEARCH FACILITIES CONSTRUCTIONC06RR018928 · NCRR · J. DAVID GLADSTONE INSTITUTES · PI MAHLEY, ROBERT W. · 2003 to 2003
$2.1M
NCRR NIH HHS C06 RR018928NIAID NIH HHS DP2 AI112244NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI027767NIAID NIH HHS R01 AI097552NIAID NIH HHS T32 AI007334
6 · The paper itself

Abstract

Understanding the host immune response to vaginal exposure to RNA viruses is required to combat sexual transmission of this class of pathogens. In this study, using lymphocytic choriomeningitis virus (LCMV) and Zika virus (ZIKV) in wild-type mice, we show that these viruses replicate in the vaginal mucosa with minimal induction of antiviral interferon and inflammatory response, causing dampened innate-mediated control of viral replication and a failure to mature local antigen-presenting cells (APCs). Enhancement of innate-mediated inflammation in the vaginal mucosa rescues this phenotype and completely inhibits ZIKV replication. To gain a better understanding of how this dampened innate immune activation in the lower female reproductive tract may also affect adaptive immunity, we modeled CD8 T cell responses using vaginal LCMV infection. We show that the lack of APC maturation in the vaginal mucosa leads to a delay in CD8 T cell activation in the draining lymph node and hinders the timely appearance of effector CD8 T cells in vaginal mucosa, thus further delaying viral control in this tissue. Our study demonstrates that vaginal tissue is exceptionally vulnerable to infection by RNA viruses and provides a conceptual framework for the male to female sexual transmission observed during ZIKV infection.

Indexed as

AnimalsAntigen-Presenting CellsCD8-Positive T-LymphocytesFemaleImmunity, InnateLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, KnockoutVaginaVirus ReplicationZika VirusZika Virus Infection

Identifiers

PMID27852793
PMCPMC5154948
OpenAlexW2554118406

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.